About Oracle Head and Neck Cancer UK
Oracle Head and Neck Cancer UK funds ground-breaking research projects in imaging, drug development, targeted therapies, biology and surgery to develop treatments which will improve the chances of survival and quality of life of head and neck cancer patients. With supporters donations Oracle can achieve its goal of beating this type of cancer.
What makes Oracle Cancer UK different?
Oracle fills a ‘research gap’; by focussing its funding on early-stage research projects, Oracle is laying the scientific and technical foundations for larger scale clinical trials, helping to bring real benefit to patients. Because of their lack of immediate commercial benefit, funding is not always made available to these early-stage projects by larger funding bodies. This highlights the importance of donations from people you.
The charity also works across 4 key areas, summarised below:
Research: Backing initiatives that enhance understanding of head and neck cancers, advance treatment options, and tackle existing gaps in care.
Awareness: Creating and supporting efforts to raise public awareness about head and neck cancers.
Collaboration: Encouraging the development of best practices across the head and neck cancer community.
Patient and Carer Engagement: Prioritising insights into the experiences of patients and carers to improve their journey and overall support.
How your donations make an impact:
-
£100 is enough to buy one of our Oracle PhD scientists a simple pipette, an essential piece of equipment for accurately measuring expensive chemicals in the lab.
-
£400 is the cost for an Oracle PhD to spend a week in the lab, before any consumables or equipment costs are taken into consideration
-
£833 is the cost of two months' fees which ensures our PhD researcher receives guidance from experienced, often internationally renowned supervisors, who are leaders in their field
You may not know…
-
There are more than 12,500 new cases of head and neck cancer diagnosed in the UK each year (17,000 including thyroid cancer) and the numbers are expected to increase by 30% over the next 10 years.
-
Every day 34 people are diagnosed with head and neck cancers in the UK, and only 50% of patients start treatment within an NHS target time of 62 days.
-
It is the 4th most common cancer in men, with cases being 101% higher in men from deprived areas. Alongside this, it is the 8th most common cancer overall.
-
Only 1% of Cancer Research UK funding last year was spent on head and neck cancer research.
-
72% of middle throat cancer is caused by the Human Papillomavirus (HPV)
-
In recent years, there has been a 47% increase in throat cancers.
-
Only 33% of Head and Neck cancers are diagnosed early, resulting in poor survival rates and outcomes.
Ways to support the Charity
Donate to Oracle - you can donate via online-form, direct debit or by leaving a gift in your will.
Fundraise for Oracle by organising an event like a coffee morning or a jumble sale. If you’re more adventurous, why not take part in one of their charity challenges. Other ways to get involved include organising a collection tin or by asking friends to donate when you celebrate a life event such as a birthday.
Oracle Head and Neck Cancer UK also hosts a number of its own fundraising events such as concerts, golf days and free evenings where you can meet the scientists behind the breakthroughs.
